Part I: Immunotherapy Against Amyloid-b in Alzheimer's Disease
1. Immunotherapy Against Amyloid-β in Alzheimer's Disease: An Overview
Niels D. Prins
2. Active Immunization Against the Amyloid-β Peptide
Enchi Liu and J. Michael Ryan
3. Immunotherapy Against N-Truncated Amyloid-β Oligomers
Thomas A. Bayer and Oliver Wirths
4. Immunotherapy Against Amyloid-β Protofibrils: Opportunities and Challenges
Lars Lannfelt
Part II: Immunotherapy in Other Neurodegenerative Disorders
5. Immunotherapy Against α-Synuclein Pathology
Elvira Valera and Eliezer Masliah
6. Extracellular α-Synuclein as a Target for Immunotherapy
Jun Sung Lee and Seung-Jae Lee
7. Immunotherapy of Parkinson's Disease
Achim Schneeberger, Suzanne Hendrix, and Markus Mandler
8. Tau Immunotherapy
Einar M. Sigurdsson
9. Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms
Kiran Yanamandra, Marc I. Diamond, and David M. Holtzman
10. Immunotherapy on Experimental Models for Huntington's Disease
Anne Messer
Part III: Biomarkers for Neurodegenerative Disorders
11. Cerebrospinal Fluid Biomarkers in Alzheimer's Disease
Henrik Zetterberg and Jonathan M. Schott
12. Volumetric MRI as a Diagnostic Tool in Alzheimer's Disease
Eric Westman, Lena Cavalin, and Lars-Olof Wahlund
13. PET Imaging as a Diagnostic Tool in Alzheimer´s Disease
Juha O. Rinne
14. Αlpha-Synuclein as a Diagnostic Biomarker for Parkinson's Disease
Joakim Bergström and Martin Ingelsson
15. Imaging as a Diagnostic Tool in Parkinson's Disease
Johan Wikström and Torsten Danfors
16. Mass Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative Diseases
Sravani Musunuri, Ganna Shevchenko, and Jonas Bergquist